Dunedin-based cancer diagnostic specialist Pacific Edge
capped off a fine week by announcing it had completed the
first commercial sales of Cxbladder tests.
Chief executive David Darling said the sale signalled the
start of the commercial revenue for the company in the United
The tests were order by US-based clinicians and processed in
Pacific Edge USA's custom laboratory in Hershey,
''The building blocks are in place to achieve commercial
success in the US, the world's largest health market,'' Mr
''We are now starting to work with leading patient awareness
to complement the growing uptake by clinicians.''
Last week, Pacific Edge finalised an agreement with FedMed,
in the US to enable 40 million Americans to have access to
CXbladder. On Thursday, the company was named supreme winner
at the New Zealand innovation awards.